Know Your Enemy: Potential Role of Cabergoline to Target Neoangiogenesis in Endometriosis

Antonio Simone Laganà, Simone Garzon, Jvan Casarin, Ricciarda Raffaelli, Antonella Cromi, Massimo Piergiuseppe Franchi, Fabio Ghezzi
Journal of investigative surgery : the official journal of the Academy of Surgical Research · 2020 · vol. 34(8) , pp. 902–903 · doi:10.1080/08941939.2020.1725191 · PMID:32046558 · W3006400327
letter OA: bronze CC0 ⤵ 4 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigates the potential of cabergoline, a dopamine D2 receptor agonist, to inhibit neoangiogenesis and thus treat endometriosis by targeting vascular endothelial growth factor A.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic inflammatory gynecologic disease characterized by the presence and growth of endometrial-like tissue outside the uterine cavity, with an estimated prevalence of 10% in re...

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Cabergoline Cabergoline Female Humans Neovascularization, Pathologic Neovascularization, Pathologic

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-30T06:09:04.529024+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:17.025735+00:00
License: CC0 · commercial use OK